Natural History of Prenatally Identified Children With 48, XXYY Syndrome in Infancy and Early Childhood

48,XXYY syndrome is a rare sex chromosome aneuploidy (SCA) associated with a variable profile of neurodevelopmental and medical. The limited information available in the literature is almost exclusively limited to postnatally diagnosed cases. This study aims to describe the early medical and developmental features of prenatally identified 48,XXYY infants, The eXtraordinarY Babies Study prospectively follows children prenatally identified to be at high risk for SCA with annual medical and neurodevelopmental evaluations. Data presented herein include the prevalence of medical conditions, developmental milestones, developmental and adaptive functioning assessment scores, and therapy utilization in 15 participants confirmed to have 48,XXYY. Comparisons were made with 47,XYY and 47,XXY males also enrolled in the eXtraordinarY Babies Study, the general population and a 2008 cohort of individuals postnatally identified 48,XXYY. Infants and young chlidren with 48,XXYY exhibited a range of early medical features, including elevated rates of feeding and GI disorders (breastfeeding difficulties, gastroesophageal reflux, and eosinophilic esophagitis), allergic disorders (food allergies and environmental allergies), and hypotonia. Developmental and adaptive functioning scores identified variable delays in motor, communication, and social domains, with nearly all infants receiving speech therapy, physical and/or occupational therapy due to delays or proactive developmental care. Medical and developmental findings were more prevalent in 48,XXYY compared to the 47,XYY and 47,XXY cohorts, although considerable individual variability and overlap in developmental functioning were observed across groups. Compared to the 2008 postnatally identified 48,XXYY cohort, infants identified prenatally received earlier intervention services, and developmental outcomes in the first years of life were similar between the two groups. Prenatal identification of 48,XXYY provides opportunity for early developmental monitoring, anticipatory guidance, and proactive referrals for medical evaluations and intervention. These findings provide valuable insights for genetic counselors and healthcare providers, emphasizing the spectrum of medical and developmental findings and the importance of early and proactive care to support individual outcomes. Prospective study of this prenatally identified cohort will provide important data about the natural history and phenotypic variability in XXYY, as well as identification of predictors of health and developmental outcomes. Trial Registration: ClinicalTrials.gov identifier: NCT03396562.

Authors

Institutions

Publication Details

Journal
American Journal of Medical Genetics Part A
Published
2026-11-18
DOI
https://doi.org/10.1002/ajmg.a.70308
Primary Topic
Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Natural History of Prenatally Identified Children With 48, XXYY Syndrome in Infancy and Early Childhood

Karli S. Swenson, Shanlee Davis, Nicole R. Tartaglia, Samantha Bothwell et al.
2 links
American Journal of Medical Genetics Part A
Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
article

Natural History of Prenatally Identified Children With 48, XXYY Syndrome in Infancy and Early Childhood

Karli S. Swenson, Shanlee Davis, Nicole R. Tartaglia, Samantha Bothwell, Susan Howell, Chijioke Ikomi, Kayla Nocon, Judith Ross
article en

Abstract

48,XXYY syndrome is a rare sex chromosome aneuploidy (SCA) associated with a variable profile of neurodevelopmental and medical. The limited information available in the literature is almost exclusively limited to postnatally diagnosed cases. This study aims to describe the early medical and developmental features of prenatally identified 48,XXYY infants, The eXtraordinarY Babies Study prospectively follows children prenatally identified to be at high risk for SCA with annual medical and neurodevelopmental evaluations. Data presented herein include the prevalence of medical conditions, developmental milestones, developmental and adaptive functioning assessment scores, and therapy utilization in 15 participants confirmed to have 48,XXYY. Comparisons were made with 47,XYY and 47,XXY males also enrolled in the eXtraordinarY Babies Study, the general population and a 2008 cohort of individuals postnatally identified 48,XXYY. Infants and young chlidren with 48,XXYY exhibited a range of early medical features, including elevated rates of feeding and GI disorders (breastfeeding difficulties, gastroesophageal reflux, and eosinophilic esophagitis), allergic disorders (food allergies and environmental allergies), and hypotonia. Developmental and adaptive functioning scores identified variable delays in motor, communication, and social domains, with nearly all infants receiving speech therapy, physical and/or occupational therapy due to delays or proactive developmental care. Medical and developmental findings were more prevalent in 48,XXYY compared to the 47,XYY and 47,XXY cohorts, although considerable individual variability and overlap in developmental functioning were observed across groups. Compared to the 2008 postnatally identified 48,XXYY cohort, infants identified prenatally received earlier intervention services, and developmental outcomes in the first years of life were similar between the two groups. Prenatal identification of 48,XXYY provides opportunity for early developmental monitoring, anticipatory guidance, and proactive referrals for medical evaluations and intervention. These findings provide valuable insights for genetic counselors and healthcare providers, emphasizing the spectrum of medical and developmental findings and the importance of early and proactive care to support individual outcomes. Prospective study of this prenatally identified cohort will provide important data about the natural history and phenotypic variability in XXYY, as well as identification of predictors of health and developmental outcomes. Trial Registration: ClinicalTrials.gov identifier: NCT03396562.

American Journal of Medical Genetics Part A
Alfred I. duPont Hospital for Children (US), Community Health Systems - Dupont Hospital (US), Children's Hospital Colorado (US), Nemours Children's Health System (US), Department of Services for Children Youth and their Families (US), University of Colorado Anschutz Medical Campus (US)
Georgia Clinical and Translational Science Alliance, National Institutes of Health, National Center for Advancing Translational Sciences, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Good health and well-being
Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon